Global Carotid Artery Disease Market Growth, Share, Size, Trends and Forecast (2025 - 2031)
By Diagnosis &
Treatment; Diagnosis, Treatment and Medications - Cholesterol-Lowering Statins, Antiplatelet Drugs and Antihypertensive Drugs, Surgical Procedures - Carotid Endarterectomy, Carotid Artery Angioplasty & Stenting and Carotid Artery Bypass.By End-Use;
Hospital & Clinics, Ambulatory Surgical Centers, Pharmacies and Others.By Geography;
North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2021 - 2031).Introduction
Global Carotid Artery Disease Market (USD Million), 2021 - 2031
In the year 2024, the Global Carotid Artery Disease Market was valued at USD 12,098.09 million. The size of this market is expected to increase to USD 16,027.72 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 4.1%.
Carotid artery disease is a significant health concern as it disrupts the normal flow of oxygen-enriched blood to the brain, often resulting from blockages caused by the accumulation of calcium and cholesterol. Effective medication plays a pivotal role in managing and potentially removing these blockages, ensuring uninterrupted blood flow through the carotid arteries. The market for carotid artery disease treatment is segmented across various regions globally, including South America, North America, Europe, Asia-Pacific, and the Middle East and Africa. North America is poised to dominate the carotid artery stenosis market, owing to its advanced healthcare infrastructure and the high prevalence of cardiovascular diseases in the region. Simultaneously, the Asia-Pacific region is expected to experience significant growth, driven by increasing awareness about cardiovascular health and escalating healthcare investments.
The carotid artery disease market faces several challenges that could potentially impede its growth trajectory. Escalating costs associated with treatments and diagnostic procedures for chronic diseases pose a significant barrier, potentially discouraging patients from seeking timely medical intervention. Additionally, the slow pace of diagnosis and stringent regulatory requirements present further obstacles to market expansion. However, with the active participation of key players and ongoing investments in research and development, the carotid artery disease market is poised to maintain its foothold and witness sustained growth in the coming years. Continuous innovation and collaborative efforts within the healthcare industry are essential to address the evolving needs of patients and overcome existing market challenges.
The carotid artery disease market holds significant potential for growth, driven by advancements in medical treatments and increasing awareness about cardiovascular health. Despite the challenges, sustained investment in research and development, along with strategic collaborations among industry stakeholders, will be instrumental in overcoming barriers and unlocking new opportunities for market expansion. This underscores the importance of proactive measures and collective efforts to address the complex healthcare needs associated with carotid artery disease.
Global Carotid Artery Disease Market Recent Developments
-
In March 2024, Silk Road Medical launched its tapered Enroute transcarotid stent system in the USA, enhancing customization options for transcarotid artery revascularization (TCAR) procedures and improving their primary product line.
-
In July 2023, the US Centers for Medicare & Medicaid Services (CMS) issued a preliminary proposed national coverage determination (NCD) for carotid stenting. This suggests that CMS considers it appropriate and essential for Medicare patients with symptomatic carotid artery stenosis of at least 50% and asymptomatic carotid artery stenosis of at least 70%.
Segment Analysis
This report extensively covers different segments of Global Carotid Artery Disease Market and provides an in depth analysis (including revenue analysis for both historic and forecast periods) for all the market segments. In this report, the analysis for every market segment is substantiated with relevant data points and, insights that are generated from analysis of these data points (data trends and patterns).
Carotid artery disease: symptoms sudden numbness or weakness in the face or limbs, often on only one side of the body, sudden trouble speaking and understanding, sudden trouble seeing in one or both eyes, sudden dizziness or loss of balance, sudden, severe headache with no known cause. Vascular surgeons treat carotid artery disease. Carotid artery treatment without surgery can be done by having a heart-healthy diet. A stethoscope will be used to listen to the arteries in your neck. A bruit (pronounced broo-ee) is an irregular rushing sound that can indicate carotid artery damage. When there are obstructions, however, bruits are not always present, and they can be heard even when the blockage is slight. Life expectancy with blocked carotid artery is at least 3-5 years. Carotid artery test can detect narrowing, or stenosis of the carotid arteries.
Global Carotid Artery Disease Segment Analysis
In this report, the Global Carotid Artery Disease Market has been segmented by Diagnosis & Treatment, End-Use and Geography.
Global Carotid Artery Disease Market, Segmentation by Diagnosis & Treatment
The Global Carotid Artery Disease Market has been segmented by Diagnosis & Treatment into Diagnosis, Treatment, Medications and Surgical Procedures.
The carotid artery disease market is segmented based on various types of treatments and diagnostic modalities. In terms of diagnosis, the market includes Duplex Ultrasound, Compound Tomography, Magnetic Resonance Imaging (MRI), and other imaging techniques. These diagnostic methods play a crucial role in accurately assessing the extent of carotid artery disease and determining the most appropriate treatment approach for patients.
Furthermore, the treatment segment of the market encompasses different therapeutic interventions aimed at managing carotid artery disease. This includes antihypertensive drugs, which help control blood pressure levels, antiplatelet drugs that prevent blood clots from forming, and cholesterol-lowering statins to manage lipid levels. Additionally, surgical interventions are available for more severe cases of carotid artery disease, including carotid artery angioplasty, carotid artery bypass surgery, and carotid endarterectomy. These surgical procedures are performed to remove blockages in the carotid arteries and restore proper blood flow to the brain. Overall, the segmentation of the carotid artery disease market based on treatment and diagnosis allows for a comprehensive approach to patient care and management.
Global Carotid Artery Disease Market, Segmentation by End-Use
The Global Carotid Artery Disease Market has been segmented by End-Use into Hospital & Clinics, Ambulatory Surgical Centers, Pharmacies and Others.
Clinics and hospitals play a pivotal role as primary care providers and treatment centers for patients with carotid artery disease. These facilities offer comprehensive diagnostic services, including imaging studies and specialized consultations with vascular specialists, enabling accurate diagnosis and treatment planning for individuals with suspected or confirmed carotid artery disease.
Pharmacies also serve as key end-users in the carotid artery disease market, providing access to medications prescribed for managing this condition. Patients with carotid artery disease often require long-term pharmacological therapy to control risk factors such as hypertension, hyperlipidemia, and platelet aggregation. Pharmacies play a vital role in dispensing these medications, ensuring patient adherence to treatment regimens, and offering counseling on medication usage and potential side effects.
Global Carotid Artery Disease Market, Segmentation by Geography
In this report, the Global Carotid Artery Disease Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.
Global Carotid Artery Disease Market Share (%), by Geographical Region, 2024
The carotid artery disease market is segmented across various regions, including South America, North America, Asia-Pacific, Europe, and the Middle East and Africa. Among these regions, North America is anticipated to hold the largest share in the market in the forthcoming years. This growth is attributed to several factors, including the increasing prevalence of life-threatening diseases and the aging population in countries such as the United States and Canada. The rise in the older generation contributes to a higher incidence of carotid artery disease, driving demand for treatment and management options.
Europe and Asia-Pacific are expected to experience robust growth compared to previous years in the carotid artery disease market. Government investments in healthcare infrastructure and initiatives aimed at improving access to quality healthcare services are major drivers of market growth in these regions. Additionally, significant advancements in treatment modalities, infrastructure development, and the introduction of new drugs further contribute to the expansion of the carotid artery disease market in Europe and Asia-Pacific. These regions present lucrative opportunities for market players to capitalize on the growing demand for effective treatment options and address the evolving healthcare needs of the population.
Market Trends
This report provides an in depth analysis of various factors that impact the dynamics of Global Carotid Artery Disease Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.
Drivers, Restraints and Opportunities
Drivers:
- Growing Prevalence of Cardiovascular Diseases
- Advancements in Medical Technology
-
Increasing Healthcare Expenditure - The increase in healthcare expenditure worldwide reflects a concerted effort to enhance healthcare accessibility and quality. Government initiatives aimed at bolstering healthcare infrastructure, coupled with rising public awareness about cardiovascular diseases like carotid artery disease, have significantly contributed to this trend. As healthcare spending continues to rise, patients have greater access to advanced diagnostic tools, specialized treatment facilities, and medical expertise, enabling timely detection and management of conditions such as carotid artery disease.
This surge in healthcare investment not only improves the overall quality of care but also drives the demand for innovative treatment options for carotid artery disease. Patients are more inclined to seek medical intervention and adhere to treatment plans when healthcare services are readily available and affordable. Consequently, the market for carotid artery disease treatments experiences growth as healthcare expenditure translates into increased patient volumes and demand for therapeutic solutions.
Restraints:
- Escalating Healthcare Costs
- Slow Diagnosis Process
-
Stringent Regulatory Requirements - Strict regulatory standards and requirements significantly impact the carotid artery disease market by imposing rigorous guidelines for the approval and marketing of medical devices and treatments. Companies operating in this space must navigate through complex regulatory pathways, which often involve extensive documentation, clinical trials, and adherence to safety and efficacy standards. Compliance with these regulations not only adds to the time and resources required for product development but also increases overall costs. Moreover, the stringent regulatory landscape can act as a barrier to entry for smaller companies and startups with limited resources, hindering their ability to innovate and bring new solutions to market.
The stringent regulatory environment can stifle innovation within the carotid artery disease market. The extensive regulatory requirements may discourage companies from investing in research and development efforts to explore novel therapies or technologies. Additionally, the lengthy approval processes associated with regulatory compliance can delay the introduction of new products into the market, limiting patient access to potentially beneficial treatments. Overall, while regulatory standards are essential for ensuring patient safety and product efficacy, striking a balance between compliance and fostering innovation is crucial for driving advancements in carotid artery disease management.
Opportunities:
- Advancements in Treatment Modalities
- Rising Healthcare Expenditure
-
Focus on Preventive Healthcare - The increasing focus on preventive healthcare presents a significant opportunity for addressing cardiovascular risk factors, including carotid artery disease, at an early stage. Public health initiatives and awareness campaigns are playing a crucial role in educating the population about the importance of cardiovascular health and the risk factors associated with vascular diseases. Screening programs designed to identify individuals at risk for conditions such as carotid artery disease offer a proactive approach to early intervention and disease management.
Healthcare providers are well-positioned to capitalize on this trend by offering comprehensive screening services and preventive care programs tailored to at-risk populations. By implementing routine screenings and assessments, healthcare professionals can identify individuals with early signs of carotid artery disease or predisposing factors such as hypertension, diabetes, or high cholesterol. Early detection allows for timely intervention strategies, including lifestyle modifications, medication management, and, if necessary, surgical interventions, thereby reducing the risk of complications associated with advanced disease progression. Moreover, investing in preventive care programs not only improves patient outcomes but also contributes to reducing healthcare costs associated with managing advanced stages of carotid artery disease.
Competitive Landscape Analysis
Key players in Global Carotid Artery Disease Market include
- W. L. Gore & Associates, Inc
- Becton
- Dickinson And Company
- Terumo Corporation
- Hitachi, Ltd
- Silk Road Medical, Inc.
- Abbott
- Medtronic
In this report, the profile of each market player provides following information:
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Diagnosis & Treatment
- Market Snapshot, By End-Use
- Market Snapshot, By Region
- Global Carotid Artery Disease Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
- Growing Prevalence of Cardiovascular Diseases
- Advancements in Medical Technology
- Increasing Healthcare Expenditure
- Restraints
- Escalating Healthcare Costs
- Slow Diagnosis Process
- Stringent Regulatory Requirements
- Opportunities
- Advancements in Treatment Modalities
- Rising Healthcare Expenditure
- Focus on Preventive Healthcare
- Drivers
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Competitive Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Global Carotid Artery Disease Market, By Diagnosis & Treatment, 2021 - 2031 (USD Million)
- Diagnosis
- Treatment
- Medications
- Cholesterol-Lowering Statins
- Antiplatelet Drugs
- Antihypertensive DRUGS
- Surgical Procedures
- Carotid Endarterectomy
- Carotid Artery Angioplasty & Stenting
- Carotid Artery Bypass
- Global Carotid Artery Disease Market, By End-Use, 2021 - 2031 (USD Million)
- Hospital & Clinics
- Ambulatory Surgical Centers
- Pharmacies
- Others
- Global Carotid Artery Disease Market, By Geography, 2021 - 2031 (USD Million)
- North America
- United States
- Canada
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Nordic
- Benelux
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia & New Zealand
- South Korea
- ASEAN (Association of South East Asian Countries)
- Rest of Asia Pacific
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- North America
- Global Carotid Artery Disease Market, By Diagnosis & Treatment, 2021 - 2031 (USD Million)
- Competitive Landscape
- Company Profiles
- W. L. Gore & Associates, Inc
- Becton
- Dickinson And Company
- Terumo Corporation
- Hitachi, Ltd
- Silk Road Medical, Inc.
- Abbott
- Medtronic
- Company Profiles
- Analyst Views
- Future Outlook of the Market